Getting TRAIL back on track for cancer therapy
Johannes Lemke(University College London), Henning Walczak(University of Cologne)
Cited by 453
Related Papers
Holding RIPK1 on the Ubiquitin Leash in TNFR1 Signaling
|Trends in Cell Biology|2016|175
Proteasome Inhibition Sensitizes Hepatocellular Carcinoma Cells, But Not Human Hepatocytes, to TRAIL *
|Hepatology|2005|171
The linear ubiquitin chain assembly complex regulates <scp>TRAIL</scp> ‐induced gene activation and cell death
|The EMBO Journal|2017|108
LUBAC deficiency perturbs TLR3 signaling to cause immunodeficiency and autoinflammation
|The Journal of Experimental Medicine|2016|90
Potent pro-apoptotic combination therapy is highly effective in a broad range of cancers
|Cell Death and Differentiation|2021|18